Your browser doesn't support javascript.
loading
Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals.
Juillerat, Pascal; Wasan, Sharmeel K; Fowler, Sharyle A; Friedman, Sonia; Pabby, Vikas K; Coukas, Jennifer A; Barto, Amy E; Pellish, Randall; Germansky, Katharine A; Cheifetz, Adam S; Korzenik, Joshua R; Farraye, Francis A; Yajnik, Vijay.
Affiliation
  • Juillerat P; *Department of Gastroenterology & Hepatology, MGH Crohn's & Colitis Center, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts; †Division of Gastroenterology, Clinic of Visceral Surgery & Medicine, Bern University Hospital Inselspital, Bern, Switzerland; ‡Gastroenterology, Boston University School of Medicine, Boston, Massachusetts; §Division of Gastroenterology, Brigham & Women's Hospital, Boston, Massachusetts; ‖Gastroenterology, Lahey Clinic, Bu
Inflamm Bowel Dis ; 19(11): 2457-63, 2013 Oct.
Article in En | MEDLINE | ID: mdl-23962896

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Integrin alpha4 / Antibodies, Monoclonal, Humanized / Immunosuppressive Agents Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2013 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Crohn Disease / Integrin alpha4 / Antibodies, Monoclonal, Humanized / Immunosuppressive Agents Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2013 Document type: Article Country of publication: United kingdom